Page last updated: 2024-08-24

amprenavir and Stevens-Johnson Syndrome

amprenavir has been researched along with Stevens-Johnson Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies

Other Studies

1 other study(ies) available for amprenavir and Stevens-Johnson Syndrome

Article	Year
Amprenavir: a new HIV protease inhibitor. The Medical letter on drugs and therapeutics, 1999, Jul-16, Volume: 41, Issue:1057 Topics: Administration, Oral; Adolescent; Adult; Anti-HIV Agents; Carbamates; Child; Clinical Trials as Topic; Cross Reactions; Diarrhea; Drug Administration Schedule; Drug Interactions; Drug Resistance, Microbial; Exanthema; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Nausea; Stevens-Johnson Syndrome; Sulfonamides	1999

Article

Year

Amprenavir: a new HIV protease inhibitor.

The Medical letter on drugs and therapeutics, 1999, Jul-16, Volume: 41, Issue:1057

Topics: Administration, Oral; Adolescent; Adult; Anti-HIV Agents; Carbamates; Child; Clinical Trials as Topic; Cross Reactions; Diarrhea; Drug Administration Schedule; Drug Interactions; Drug Resistance, Microbial; Exanthema; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Nausea; Stevens-Johnson Syndrome; Sulfonamides

1999